CN101450176A - Traditional Chinese medicine for treating presbyopia - Google Patents
Traditional Chinese medicine for treating presbyopia Download PDFInfo
- Publication number
- CN101450176A CN101450176A CNA2008102425960A CN200810242596A CN101450176A CN 101450176 A CN101450176 A CN 101450176A CN A2008102425960 A CNA2008102425960 A CN A2008102425960A CN 200810242596 A CN200810242596 A CN 200810242596A CN 101450176 A CN101450176 A CN 101450176A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- traditional chinese
- graininess
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal preparation for treating presbyopia which is prepared from 15 concentrated traditional Chinese medicines as follows: 20-30 parts by weight of astragalus, 20-30 parts by weight of americanwater plantain, 20-30 parts by weight of korean ginseng, 20-30 parts by weight of angelica, 20-30 parts by weight of barrenwort, 20-30 parts by weight of rhizoma curculiginis, 20-30 parts by weight of atractylodes, 20-30 parts by weight of schizonepeta spike, 20-30 parts by weight of clematis root, 20-30 parts by weight of traditional chinese medicine hyssop, 20-30 parts by weight of liriope, 20-30 parts by weight of medlar and 20-30 parts by weight of rehmanniae radix, 5-10 parts by weight of asarum, 5-10 parts by weight of schisandra chinensis. The 15 concentrated traditional Chinese medicines have same concentration rate (for example, 5:1) and are weight rate, the preparation shape is oral granule shape traditional Chinese medicinal preparation. Presbyopic glasses can be took off at the soonest 10 days by taking the preparation for reading and writing, augen deepness recovers to normal augen range after being ophthalmic testing, optic nerve has full nourishment, all users need not wearing presbyopic glasses in five years follow up. The traditional Chinese medicinal preparation fills in the gaps that no medicine can cure natural presbyopia at present, and lower cost carries gospel to ordinary old person.
Description
Technical field
The present invention relates to the presbyopic Chinese medicine preparation of a kind of treatment.
Background technology
Presbyopia's doctor trained in Western medicine is referred to as presbyopia, comes across more than 40 years old more, and phacosclerosis, elasticity weakens, and the ciliary muscle contraction ability reduces and causes the regulatory function natural aging, and near point far moves, so the thing difficulty takes place closely to look.The human natural deterioration law that belongs to primary disease causes, and is due to the irreversible reason by the conclusion of doctor trained in Western medicine, so there is not the presbyopic medicine of treatment so far.Only way is worn reading glasses according to the presbyopia degree exactly, because institute's object of looking far and near is different, usually needs to overpay presbyopic glasses and extremely bothers.
Summary of the invention
The objective of the invention is: provide a kind of treatment presbyopic Chinese medicine preparation, can treat, solved the present situation of not having treatment presbyopia medicine because of spontaneous presbyopia of age.
The technical scheme that realizes the object of the invention is: the presbyopic Chinese medicine preparation of a kind of treatment, and it is by following 15 kinds of compound recipes that the graininess concentrated traditional Chinese medicine is formed, and each graininess concentrated traditional Chinese medicine consumption is as follows by weight:
The Radix Astragali 20～30, Rhizoma Alismatis 20～30, Korean Ginseng 20～30,
Radix Angelicae Sinensis 20～30, Herba Epimedii 20～30, Rhizoma Curculiginis 20～30,
Rhizoma Atractylodis 20～30, Herba Schizonepetae 20～30, Radix Clematidis 20～30,
Radix Achyranthis Bidentatae 20～30, Radix Ophiopogonis 20～30, Fructus Lycii 20～30,
The Radix Rehmanniae 20～30, Herba Asari 5～10, Fructus Schisandrae Chinensis 5～10;
Described each graininess concentrated traditional Chinese medicine cocnentration factor by weight is identical.
In the above-mentioned Chinese medicine preparation, described graininess concentrated traditional Chinese medicine cocnentration factor by weight is: the ratio of the graininess concentrated traditional Chinese medicine weight that raw materials used weight and raw material with this weight obtain; Described raw material is meant the raw material of Chinese medicine medicine (be crude Chinese medicine, also claim to give birth to Chinese medicine) or the prepared slices of Chinese crude drugs (promptly through single medicinal material preliminary working, that sell in the pharmacy, also claiming ripe Chinese medicine).
In the above-mentioned Chinese medicine preparation, described graininess concentrated traditional Chinese medicine cocnentration factor by weight is 5:1.
The dosage form of above-mentioned Chinese medicine preparation is an oral granule type Chinese medicine preparation.
Technique effect of the present invention is: Chinese medicine preparation of the present invention according to theory of Chinese medical science promptly: the natural type presbyopia all belongs to stagnated heat of liver channel, the liver weakness, based on the deficiency of vital energy, accompany blood stasis not move simultaneously, humidity hysteresis can not rise to order in meridians, cause due to optic nerve lose to support, so in line with liver heat removing, invigorating middle warmer, diuretic collateral dredging, recover the normal operation function of human body and determine the prescription foundation.In its compound recipe: the Radix Astragali, Korean Ginseng and the Radix Angelicae Sinensis collateral dredging that fills blood, to recover the effect of normal QI-blood circulation; Rhizoma Alismatis, Rhizoma Atractylodis and Radix Clematidis have the effect of promoting diuresis to eliminate damp pathogen; The Radix Rehmanniae, Fructus Lycii and Fructus Schisandrae Chinensis have and in, the effect of nourishing YIN and clearing away heat; Herba Schizonepetae has diffusing wind to dredge the effect of network; Herba Epimedii, Rhizoma Curculiginis, Radix Ophiopogonis, bosom Radix Achyranthis Bidentatae and Herba Asari have nourishing lung and kidney, and to help the effect of the foundation of acquired constitution, all recurrence due to taking drug sides play special effect altogether.Nearly ten thousand examples of clinical cure presbyopia patient.The clinical practice proof age, the presbyopia number of degrees did not wait from 150 degree～800 degree from 40～80 years old, all can be after medication remove presbyopic glasses in 10 days and more the back is stable, and the recurrence probability is extremely low.
The specific embodiment
Below in conjunction with embodiment the present invention is further described, but is not limited to this.
Embodiment 1 preparation Chinese medicine preparation A of the present invention
When preparing Chinese medicine preparation of the present invention, all carry out in the factory that obtains the GMP authentication, production method is all undertaken by the existing mode of production that meets the GMP authentication requesting, and concrete steps are as follows:
1. weigh the following 15 kinds of raw material of Chinese medicine medicines or the prepared slices of Chinese crude drugs respectively: the Radix Astragali, Rhizoma Alismatis, Korean Ginseng, Radix Angelicae Sinensis, Herba Epimedii, Rhizoma Curculiginis, Rhizoma Atractylodis, Herba Schizonepetae, Radix Clematidis, Radix Achyranthis Bidentatae, Radix Ophiopogonis, Fructus Lycii, the Radix Rehmanniae, Herba Asari, each 250Kg of Fructus Schisandrae Chinensis, then respectively by the existing mode of production that meets the GMP authentication requesting extract, concentrate, dry, make 15 kinds of graininess concentrated traditional Chinese medicines that each 50Kg cocnentration factor is 5:1 (weight ratio) respectively;
2. weigh 15 kinds of graininess concentrated traditional Chinese medicines that 1. step makes respectively, wherein the Radix Astragali, Rhizoma Alismatis, Korean Ginseng, Radix Angelicae Sinensis, Herba Epimedii, Rhizoma Curculiginis, Rhizoma Atractylodis, Herba Schizonepetae, Radix Clematidis, Radix Achyranthis Bidentatae, Radix Ophiopogonis, Fructus Lycii and the Radix Rehmanniae are by every part of 1Kg, respectively weigh 30 parts, amount to 390Kg, Herba Asari and Fructus Schisandrae Chinensis respectively weigh 10 parts by every part of 1Kg, amount to 20Kg, then, put into the blender mix homogeneously;
3. the mixture that 2. step is made is gone in the vacuum bag by 15g one is packed, after sealing, sterilization, the sterilization, makes oral granule type Chinese medicine preparation A of the present invention.
Embodiment 2 preparations Chinese medicine preparation B of the present invention
Preparation process is basic identical with embodiment 1, make oral granule type Chinese medicine preparation B of the present invention, difference is the quantity difference of 15 kinds of graininess concentrated traditional Chinese medicines 1. making of step that 2. step is weighed, the Radix Astragali, Rhizoma Alismatis, Korean Ginseng, Radix Angelicae Sinensis, Herba Epimedii, Rhizoma Curculiginis, Rhizoma Atractylodis, Herba Schizonepetae, Radix Clematidis, Radix Achyranthis Bidentatae, Radix Ophiopogonis, Fructus Lycii and the Radix Rehmanniae are by every part of 1Kg, respectively weigh 20 parts, amount to 260 parts; Herba Asari and Fructus Schisandrae Chinensis respectively weigh 5 parts by every part of 1Kg, amount to 10Kg.
Chinese medicine preparation of the present invention is not subjected to the restriction of embodiment, according to actual needs, can be by the concrete steps of embodiment 1, by in the scope of 15 kinds of graininess concentrated traditional Chinese medicine consumptions of described composition compound recipe, change the product of the consumption production various dose of 15 kinds of graininess concentrated traditional Chinese medicines, to adapt to different patients' needs.
Application example
The Chinese medicine preparation of the present invention that Application Example makes carries out clinical practice to presbyopia patient;
(1) clinical practice concrete condition:
Clinical treatment case number 500 people, wherein male, each 250 people of woman, the range of age 40～80 years old; All need wear the presbyopic glasses of the different number of degrees and could read, write and be nature presbyopia type, eye was not subjected to outside the contusion; Before the treatment, through professional ophthalmology microscope test, its augen degree of depth belongs to the presbyopia scope, optic nerve nutrition shortcoming;
Therapeutic Method:, select Chinese medicine preparation A that embodiment 1 or embodiment 2 make or B or the Chinese medicine preparation of the present invention of other various dose of making according to actual needs according to presbyopia degree, optic nerve nutriture difference; Every day 2 times, each one bag (15g), the boiled water impulsive motion one after each meal that stirs is taken in the process, and the patient avoids a coffee, tea, and raw and cold diet, in order to avoid cut down or reduce the property of medicine; Carry out once naked look reading, the aptitude tests of writing weekly; Specialty ophthalmology microscope is tested its augen degree of depth and is looked refreshing Shen through the nutrition situation, in order to the evaluation therapeutic effect; The treatment effectiveness evaluation method:
Evaluation result shows: 500 people wherein 90% (450 people) can remove the reading glasses reading, write in 14 days; Test the normal eyeball scope of its augen depth recovery through professional ophthalmology microscope, optic nerve nutrition is full, full, and reading in the fastest 10 days after individual patient is taken medicine, writing all need not to wear presbyopic glasses; 10% (50 people) was because of once suffering from other diseases during treating for residue, therefore, took medicine continuously 30 days, also reached can remove reading glasses and read, write; Test the normal eyeball scope of its augen depth recovery through professional ophthalmology microscope, optic nerve nutrition is full, full;
Treatment back Follow-up results: the presbyopia degree is basicly stable, follows up a case by regular visits to 5 years all users and still need not to wear presbyopic glasses.
The actual existing nearly 10000 people of the presbyopia patient of Chinese medicine preparation treatment of the present invention.It is low to have solved the present situation and the expenses for medicine that do not have treatment presbyopia medicine, for the old people brings glad tidings.
Claims (4)
1, the presbyopic Chinese medicine preparation of a kind of treatment is characterized in that, it is by following 15 kinds of compound recipes that the graininess concentrated traditional Chinese medicine is formed, and each graininess concentrated traditional Chinese medicine consumption is as follows by weight:
The Radix Astragali 20～30, Rhizoma Alismatis 20～30, Korean Ginseng 20～30,
Radix Angelicae Sinensis 20～30, Herba Epimedii 20～30, Rhizoma Curculiginis 20～30,
Rhizoma Atractylodis 20～30, Herba Schizonepetae 20～30, Radix Clematidis 20～30,
Radix Achyranthis Bidentatae 20～30, Radix Ophiopogonis 20～30, Fructus Lycii 20～30,
The Radix Rehmanniae 20～30, Herba Asari 5～10, Fructus Schisandrae Chinensis 5～10;
Described each graininess concentrated traditional Chinese medicine cocnentration factor by weight is identical.
2, Chinese medicine preparation according to claim 1 is characterized in that, described graininess concentrated traditional Chinese medicine cocnentration factor by weight is: the ratio of the graininess concentrated traditional Chinese medicine weight that raw materials used weight and raw material with this weight obtain; Described raw material is meant the raw material of Chinese medicine medicine or the prepared slices of Chinese crude drugs.
3, Chinese medicine preparation according to claim 1 and 2 is characterized in that, described graininess concentrated traditional Chinese medicine cocnentration factor by weight is 5:1.
4, Chinese medicine preparation according to claim 1 is characterized in that, its dosage form is an oral granule type Chinese medicine preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102425960A CN101450176A (en) | 2008-12-30 | 2008-12-30 | Traditional Chinese medicine for treating presbyopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102425960A CN101450176A (en) | 2008-12-30 | 2008-12-30 | Traditional Chinese medicine for treating presbyopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101450176A true CN101450176A (en) | 2009-06-10 |
Family
ID=40732774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008102425960A Pending CN101450176A (en) | 2008-12-30 | 2008-12-30 | Traditional Chinese medicine for treating presbyopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101450176A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520517A (en) * | 2013-10-18 | 2014-01-22 | 卞佳林 | Medicinal composition for preventing and treating presbyopia and preparation method for medicinal composition |
| CN104001024A (en) * | 2014-06-14 | 2014-08-27 | 甘元兴 | Traditional Chinese medicine formula for treating myopia and presbyopia and preparing method |
| CN104095982A (en) * | 2014-08-04 | 2014-10-15 | 毕宏生 | Compound preparation of natural plant extracts and preparing method and application thereof |
-
2008
- 2008-12-30 CN CNA2008102425960A patent/CN101450176A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520517A (en) * | 2013-10-18 | 2014-01-22 | 卞佳林 | Medicinal composition for preventing and treating presbyopia and preparation method for medicinal composition |
| CN103520517B (en) * | 2013-10-18 | 2015-08-05 | 卞佳林 | Presbyopic pharmaceutical composition of a kind of control and preparation method thereof |
| CN104001024A (en) * | 2014-06-14 | 2014-08-27 | 甘元兴 | Traditional Chinese medicine formula for treating myopia and presbyopia and preparing method |
| CN104095982A (en) * | 2014-08-04 | 2014-10-15 | 毕宏生 | Compound preparation of natural plant extracts and preparing method and application thereof |
| CN104095982B (en) * | 2014-08-04 | 2015-12-02 | 毕宏生 | A kind of natural plant extracts compound formulation and its production and use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102133357B (en) | Pill with function of strengthening muscles and bones and preparation method thereof | |
| CN103585514A (en) | Traditional Chinese medicine composition for treating stomach cancer, application and preparation | |
| CN102526345B (en) | Chinese medicinal composition for treating hypertension | |
| CN103071028A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura | |
| CN101450176A (en) | Traditional Chinese medicine for treating presbyopia | |
| CN101797342A (en) | Traditional Chinese medicine for treating rheumatoid and chronic infectious arthritis | |
| CN103735996A (en) | Traditional Chinese medicine composition for treating infantile diarrhea | |
| CN103330837B (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
| CN101244183B (en) | Chinese medicine composing prescription for treating children's lymphoglandulae mesentericae intumesce | |
| CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
| CN1943661B (en) | A Chinese traditional medicinal composition and its preparation method | |
| CN103816337A (en) | Traditional Chinese medicinal composition for treating delayed menstrual cycle | |
| CN101675961B (en) | A medicinal preparation for treating breast cancer and preparation method thereof | |
| CN104161971A (en) | Traditional Chinese medicine composition for treating preceded menorrhea | |
| CN104436121A (en) | Medicine for treating irregular menstruation, lower abdominal distension and persistent failure to conceive | |
| CN103055136A (en) | Chinese herbal medicine for treating rheumatoid arthritis | |
| CN108324874A (en) | Treat syndrome of intermingled heat and cold urarthritis on behalf of the tea | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN113827668B (en) | Traditional Chinese medicine compound preparation for treating degenerative gonarthritis and preparation method thereof | |
| CN102266417B (en) | Chinese medicine for treating acquired immune deficiency syndrome and preparation method and administration method thereof | |
| CN101972306B (en) | Chinese medicinal capsule for treating chronic pelvic inflammatory disease | |
| CN105106396A (en) | Oral medicine capable of effectively treating localized scleroderma and preparation method thereof | |
| CN104984004A (en) | Oral medicine for treating whole body lymphadenectasis and preparing method thereof | |
| CN104666911A (en) | Medicine for treating urticaria and preparation method thereof | |
| CN105250816A (en) | Medicine composition for treating phlegmatic hygrosis and preparation method and application of medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090610 |